Whether the complex and time-intensive requirements for administering PRP warrants its use for intra-articular (IA) therapy in OA is in question and should be examined. If PRP is at least or even more effective than corticosteroids or hyaluronic acid (HA) for relieving pain and restoring function, then it can be recommended with confidence to OA patients who are appropriate candidates for intra-articular injections. In addition, if its beneficial effects are more durable than other IA agents, it may become the preferred treatment of choice
Introduction: Osteoarthritis (OA) is the most frequently presented joint disorder, and its treatment...
Background: Platelet-rich plasma (PRP) is a natural concentrate of autologous blood growth factors e...
Intra-articular injection of platelet-rich plasma (PRP) has been established as a suitable treatment...
Whether the complex and time-intensive requirements for administering PRP warrants its use for intra...
Platelet-Rich Plasma (PRP) has emerged as a promising treatment of OA, particularly in large joints....
Knee osteoarthritis (OA) is estimated to affect more than 10% of the population, with a lifetime ris...
Intra-articular injections of platelet-rich plasma (PRP) and other novel blood-derived products deve...
Intra-articular injections of platelet-rich plasma (PRP) and other novel blood-derived products deve...
Intra-articular injection of platelet-rich plasma (PRP) has been established as a suitable treatment...
Osteoarthritis (OA) is the most common joint disease and the prevalence of knee OA among athletes is...
Knee osteoarthritis (OA) is a common debilitating chronic disease. Up to one in 5 people over the ag...
Introduction Knee osteoarthritis (OA) is the most common articular disease. Different methods are us...
Context There is no definite treatment strategy capable of decreasing destruction of cartilage and e...
Background: Increased physical activities and prolonged life expectancies, coupled with biomechanica...
Background: Platelet rich plasma (PRP) is a concentrate extract of platelets from autologous blood. ...
Introduction: Osteoarthritis (OA) is the most frequently presented joint disorder, and its treatment...
Background: Platelet-rich plasma (PRP) is a natural concentrate of autologous blood growth factors e...
Intra-articular injection of platelet-rich plasma (PRP) has been established as a suitable treatment...
Whether the complex and time-intensive requirements for administering PRP warrants its use for intra...
Platelet-Rich Plasma (PRP) has emerged as a promising treatment of OA, particularly in large joints....
Knee osteoarthritis (OA) is estimated to affect more than 10% of the population, with a lifetime ris...
Intra-articular injections of platelet-rich plasma (PRP) and other novel blood-derived products deve...
Intra-articular injections of platelet-rich plasma (PRP) and other novel blood-derived products deve...
Intra-articular injection of platelet-rich plasma (PRP) has been established as a suitable treatment...
Osteoarthritis (OA) is the most common joint disease and the prevalence of knee OA among athletes is...
Knee osteoarthritis (OA) is a common debilitating chronic disease. Up to one in 5 people over the ag...
Introduction Knee osteoarthritis (OA) is the most common articular disease. Different methods are us...
Context There is no definite treatment strategy capable of decreasing destruction of cartilage and e...
Background: Increased physical activities and prolonged life expectancies, coupled with biomechanica...
Background: Platelet rich plasma (PRP) is a concentrate extract of platelets from autologous blood. ...
Introduction: Osteoarthritis (OA) is the most frequently presented joint disorder, and its treatment...
Background: Platelet-rich plasma (PRP) is a natural concentrate of autologous blood growth factors e...
Intra-articular injection of platelet-rich plasma (PRP) has been established as a suitable treatment...